Evidence map›Paper›PMID 32486518›Full record

ArticleMolecules (Basel, Switzerland)2020

Catalyst-Solvent System for PASE Approach to Hydroxyquinolinone-Substituted Chromeno[2,3-

Fedor V Ryzhkov, Yuliya E Ryzhkova, Michail N Elinson, Stepan V Vorobyev, Artem N Fakhrutdinov, Anatoly N Vereshchagin, Mikhail P Egorov

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2022
    Article
  2. Multicomponent Synthesis of 2-(2,4-Diamino-3-cyano-5Molecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Fedor V RyzhkovN. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, Leninsky pr. 47, Moscow 119991, Russia.ORCID 0000-0002-5844-6019
Yuliya E RyzhkovaN. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, Leninsky pr. 47, Moscow 119991, Russia.ORCID 0000-0002-5826-2279
Michail N ElinsonN. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, Leninsky pr. 47, Moscow 119991, Russia.ORCID 0000-0002-4647-5410
Stepan V VorobyevDepartment of Organic Chemistry and Petroleum Chemistry, Gubkin Russian State University of Oil and Gas, 65 Leninsky Prospect, Moscow 119991, Russia.ORCID 0000-0001-6042-6394
Artem N FakhrutdinovN. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, Leninsky pr. 47, Moscow 119991, Russia.
Anatoly N VereshchaginN. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, Leninsky pr. 47, Moscow 119991, Russia.
Mikhail P EgorovN. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, Leninsky pr. 47, Moscow 119991, Russia.
N.D. Zelinsky Institute of Organic Chemistry · RUGubkin Russian State University of Oil and Gas · RU

Funding

Russian Foundation for Basic Research 18-03-00212
6 · The paper itself

Abstract

The Pot, Atom, and Step Economy (PASE) approach is based on the Pot economy principle and unites it with the Atom and Step Economy strategies; it ensures high efficiency, simplicity and low waste formation. The PASE approach is widely used in multicomponent chemistry. This approach was adopted for the synthesis of previously unknown hydroxyquinolinone substituted chromeno[2,3-

Indexed as

Chemistry Techniques, SyntheticAldehydesCatalysisDimerizationEthanolHydroxyquinolinesMagnetic Resonance SpectroscopyNitrilesPyridinesQuantum TheoryQuinolonesSolventsAldehydesdicyanmethaneEthanolHydroxyquinolinesNitrilespyridinePyridinesQuinolonessalicylaldehydeSolventschromeno[2,3‑b]pyridinescorrosion inhibitorhydroxyquinolinonemalononitrile dimermulticomponent reactionsNMR monitoringPASE approachsalicylaldehyde

Identifiers

PMID32486518
PMCPMC7321101
OpenAlexW3029506519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.